NCT00075803 2023-01-04
BMT CTN 0101
Medical College of Wisconsin
Phase 3 Completed
Clinical Trials
10 trialsNCT04547335 2020-09-16
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Dokuz Eylul University
Unknown
NCT00893555 2017-01-12
VORI911
University Medical Center Groningen
Phase 3 Completed
NCT01416025 2016-08-18
VoriTDM
Johns Hopkins University
Phase 4 Completed
NCT01501708 2016-05-10
Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT01148160 2014-04-10
Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy
Asan Medical Center
Terminated
NCT00418951 2012-08-07
Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00904995 2012-08-07
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01207128 2012-04-20
Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis
University of Arkansas
Phase 2 Withdrawn
NCT00152594 2006-11-14
Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
University of Cologne
Phase 3 Terminated